# Observational Small Intestine and Blood Fingerprint (SmIle) Study in Parkinson's Disease

> **NCT06003608** · — · ACTIVE_NOT_RECRUITING · sponsor: **Nimble Science Ltd.** · enrollment: 100 (estimated)

## Conditions studied

- Parkinson Disease

## Interventions

- **DEVICE:** Fluid biopsy capsule
- **DRUG:** Levodopa-Carbidopa Immediate Release

## Key facts

- **NCT ID:** NCT06003608
- **Lead sponsor:** Nimble Science Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-02-19
- **Primary completion:** 2025-02
- **Final completion:** 2025-02
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2025-01-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06003608

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06003608, "Observational Small Intestine and Blood Fingerprint (SmIle) Study in Parkinson's Disease". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06003608. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*